Previous Article | Next Article ![]()
Molecular and Cellular Biology, January 2005, p. 847-853, Vol. 25, No. 2
0270-7306/05/$08.00+0 doi:10.1128/MCB.25.2.847-853.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Marc Lenoir,
Rémy Pujol,
Jean-Luc Puel,
Philippe Brabet, and
Christian P. Hamel*
INSERM, U.583, Physiopathologie et Thérapie des Déficits Sensoriels et Moteurs, Institut des Neurosciences de Montpellier, Hôpital Saint-Eloi, Montpellier, France
Received 26 June 2004/ Returned for modification 16 September 2004/ Accepted 10 October 2004
In the cochlea, the mammalian auditory organ, fibrocytes of the mesenchymal nonsensory regions play important roles in cochlear physiology, including the maintenance of ionic and hydric components in the endolymph. Occurrence of human deafness in fibrocyte alterations underlines their critical roles in auditory function. We recently described a novel gene, Otos, which encodes otospiralin, a small protein of unknown function that is produced by the fibrocytes of the cochlea and vestibule. We now have generated mice with deletion of Otos and found that they show moderate deafness, with no frequency predominance. Histopathology revealed a degeneration of type II and IV fibrocytes, while hair cells and stria vascularis appeared normal. Together, these findings suggest that impairment of fibrocytes caused by the loss in otospiralin leads to abnormal cochlear physiology and auditory function. This moderate dysfunction may predispose to age-related hearing loss.
Present address: INSERM U.567, Institut Cochin, 75014 Paris, France.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»